Clinical Sciences

Clinical Sciences Experts

Hung Randy King Kuen

China Shineway Pharmaceutical Group Limited
Hong Kong


aged 51, is the Director of Investor Relation of the Group.  Mr Hung has more than 20 years of experience as CFO, executive director and independent non-executive director of various listed companies in Hong Kong.  He was an executive director of the Group from 2005 to 2010, and was appointed as a non-executive director of the Group in 2011 and continued to serve as an independent non-executive director of the Group from 2014 to March 2017.  Currently, Mr. Hung is also serving as a council member and the Chairman of Training Committee of the Hong Kong Institute of Directors, and the Vice Chairman of Hong Kong Investor Relations Association.

Research Interest

Life science

Global Experts from Hong Kong

Global Experts in Subject

Share This Profile